Using CRISPR/Cas9 to Encode Cellular History

Non-Exclusively Licensed

The present invention relates to systems and methods for recording and assaying cellular events, in particular gene expression. The invention provides hereto a method of determining a cellular event of interest in a cell comprising providing a cell comprising a CRISPR-Cas system, wherein the CRISPR-Cas system comprises a guide RNA that targets a selected DNA sequence and a Cas protein capable of modifying the selected DNA sequence; whereby a nucleic acid molecule encoding at least one of the guide RNA or Cas protein is operably connected in the cell with a regulatory element comprising a promoter responsive to the cellular event, and whereby expression of at least one CRISPR-Cas system component is driven by the promoter; and determining cellular event of interest based on detection of the modification of the selected DNA sequence.

Researchers

Alex Shalek / Alethe Gaillard de Saint Germain

Departments: Institute for Medical Engineering and Science
Technology Areas: Biotechnology: DNA & RNA Editing / Drug Discovery and Research Tools: Genomics & Proteomics
Impact Areas: Healthy Living

  • crispr mediated recording of cellular events
    United States of America | Granted | 11,643,669
  • crispr mediated recording of cellular events
    European Patent Convention | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.